Double-digit growth in pharmaceutical spending in US, Czech Republic

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.359, 2002-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Measuring US Pharmaceutical Industry R&D Spending

By Golec Joseph   Vernon John  

PharmacoEconomics, Vol. 26, Iss. 12, 2008-01 ,pp. : 1005-1017

Adis International

Access to resources Recommend Favorite

US healthcare spending growth hits the skids

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 570, 2009-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Czech Republic

By  

International Journal of Pharmaceutical Medicine, Vol. 21, Iss. 1, 2007-01 ,pp. : 15-17

Adis International

Access to resources Recommend Favorite

Financial Effects of Pharmaceutical Price Regulation on R&D Spending by EU versus US Firms

By Golec Joseph   Vernon John A.  

PharmacoEconomics, Vol. 28, Iss. 8, 2010-08 ,pp. : 615-628

Adis International

Access to resources Recommend Favorite

The Portugese government and pharmaceutical industry association Apifarma have agreed to cut the growth in spending on medicines through pharmacies

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 497, 2006-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite